MID-VOLUME · HOSP-MID
lovastatin Side Effects
lovastatin (also sold as Mevacor, Altoprev) sits MID-VOLUME #207 of 524 by FAERS report count. Lead signal: HOSP-MID - 27.3% mention hospitalization (6,900 reports). Demographics and serious-outcome tables follow.
Data updated 2026-05-15
- 25,229
- FAERS reports
FDA Adverse Event Reporting System extract for lovastatin. Stamp set CASELOAD · DEATH-HEAVY · HOSP-MID. How figures are compiled.
lovastatin: 27.3% mention hospitalization (6,900 reports). Death stamp DEATH-HEAVY; volume band MID-VOLUME #207 of 524 by FAERS report count.
Mid-book FAERS page for lovastatin (Mevacor) (25,229 reports). Signature HOSP-MID. Dominant age band on file: 45-64. Educational reference only.
Counts from the openFDA FAERS extract (2001–2025). Stamps CASELOAD · DEATH-HEAVY · HOSP-MID · SEX-BALANCED.
FATIGUE leads 1,518 of 25,229 reports
Who reports · age peak 45-64 (SEX-BALANCED)
Sex coding · SEX-BALANCED
Age peak 45-64 (5,392 reports)
FAERS filings rising toward 2025
Reactions in Death Reports
Death-mentioned subset is HEAVY here (2,045 reports, 8.1%). Top co-reported reactions in that subset - voluntary, not causal.
| Reaction | Reports |
|---|---|
| DEATH | 779 |
| COMPLETED SUICIDE | 146 |
| PNEUMONIA | 127 |
| CARDIAC ARREST | 108 |
| RENAL FAILURE | 108 |
| DYSPNOEA | 104 |
| DISEASE PROGRESSION | 102 |
| CARDIO-RESPIRATORY ARREST | 97 |
| RESPIRATORY FAILURE | 89 |
| FATIGUE | 87 |
| CARDIAC FAILURE CONGESTIVE | 86 |
| ASTHENIA | 81 |
| MYOCARDIAL INFARCTION | 81 |
| HYPOTENSION | 80 |
| NAUSEA | 79 |
| FALL | 76 |
| CHRONIC KIDNEY DISEASE | 71 |
| PAIN | 70 |
| SEPSIS | 70 |
| TOXICITY TO VARIOUS AGENTS | 69 |
Reactions in Hospitalization Reports
Hospitalization mid-share (6,900, 27.3%). Co-reported reactions:
| Reaction | Reports |
|---|---|
| PNEUMONIA | 529 |
| DYSPNOEA | 528 |
| FALL | 496 |
| NAUSEA | 449 |
| ASTHENIA | 441 |
| FATIGUE | 425 |
| DIARRHOEA | 397 |
| VOMITING | 356 |
| DIZZINESS | 349 |
| PAIN | 323 |
| MYOCARDIAL INFARCTION | 316 |
| CARDIAC FAILURE CONGESTIVE | 293 |
| DEHYDRATION | 291 |
| RENAL FAILURE | 279 |
| CHEST PAIN | 274 |
| ATRIAL FIBRILLATION | 267 |
| ANAEMIA | 265 |
| URINARY TRACT INFECTION | 264 |
| CEREBROVASCULAR ACCIDENT | 251 |
| HEADACHE | 249 |
How to read lovastatin FAERS figures (CASELOAD · DEATH-HEAVY · HOSP-MID)
FAERS holds 25,229 voluntary reports linked to lovastatin (Mevacor, Altoprev), 2001-2025. Death is listed on 2,045 (8.1%). Hospitalization appears on 6,900 (27.3%). Top co-reported indication: Product Used For Unknown Indication.
Mid-volume extract - treat DEATH-HEAVY · HOSP-MID as signal-detection rates next to 27.3% mention hospitalization (6,900 reports).
Read with lovastatin
Peers ranked by ABS(total_reports), then an ABS(death_share) pole; guide hop follows DEATH-HEAVY · HOSP-MID stamps.
ABS(total_reports) peer at 25,027 FAERS cases (Δ 202 lighter vs lovastatin); DEATH-HEAVY · HOSP-HEAVY · SEX-BALANCED vs this page's CASELOAD · DEATH-HEAVY · HOSP-MID · SEX-BALANCED.
ABS(total_reports) peer at 24,979 FAERS cases (Δ 250 lighter vs lovastatin); DEATH-MARKED · HOSP-MID · FEMALE-LED vs this page's CASELOAD · DEATH-HEAVY · HOSP-MID · SEX-BALANCED.
ABS(total_reports) peer at 24,883 FAERS cases (Δ 346 lighter vs lovastatin); DEATH-HEAVY · HOSP-MID · SEX-BALANCED vs this page's CASELOAD · DEATH-HEAVY · HOSP-MID · SEX-BALANCED.
ABS(total_reports) peer at 24,667 FAERS cases (Δ 562 lighter vs lovastatin); DEATH-MARKED · HOSP-LIGHT · FEMALE-LED vs this page's CASELOAD · DEATH-HEAVY · HOSP-MID · SEX-BALANCED.
ABS(death_share) pole at 62.1% death-mentioned reports (Δ 54.0 pp vs lovastatin's DEATH-HEAVY): CASELOAD · HOSP-MID.
lovastatin stamps DEATH-HEAVY · HOSP-MID; FAERS outcome shares are signal-detection rates, not incidence. Read them next to caseload CASELOAD and the label guide.